Author Conradi, Lena-Christin
-
2010 | Review
Molecular markers for response prediction in locally advanced rectal cancer. Is individualized therapy coming?
Liersch, T.; Gaedcke, J.; Grade, M.; Sprenger, T.; Conradi, L.-C.; Becker, H.& Ghadimi, B. M. (2010)
Der Onkologe, 16(8) pp. 779-788.
Springer. DOI: https://doi.org/10.1007/s00761-010-1866-y
Details DOI WoS
-
2010 | Journal Article |
Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
Sprenger, T.; Rothe, H.; Jung, K.; Christiansen, H.; Conradi, L.-C.; Ghadimi, B. M. & Becker, H. et al. (2010)
World Journal of Surgical Oncology, 8 art. 27. DOI: https://doi.org/10.1186/1477-7819-8-27
Details DOI PMID PMC WoS
-
2012 | Journal Article
HER2/neu expression in locally advanced rectal cancer cUICC II/III and its correlation with long-term prognosis
Conradi, L.-C.; Styczen, H.; Sprenger, T.; Becker, H.; Ghadimi, M. B.; Beißbarth, T. & Middel, P. et al. (2012)
Journal of Clinical Oncology, 30(4, Suppl.) pp. 493-493. DOI: https://doi.org/10.1200/jco.2012.30.4_suppl.493
Details DOI
-
2012 | Conference Abstract
Resectability and indication for chemotherapy in patients with colorectal liver metastases as assessed by medical oncologists and surgeons
Homayounfar, K.; Bleckmann, A.; Helms, H.-J.; Lordick, F.; Rueschoff, J.; Conradi, L.-C. & Sprenger, T. et al. (2012)
Journal of Clinical Oncology, 30(15) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL.
Alexandria: Amer Soc Clinical Oncology.
Details WoS
-
2012 | Journal Article |
Ultrasonic scalpel causes greater depth of soft tissue necrosis compared to monopolar electrocautery at standard power level settings in a pig model
Homayounfar, K.; Meis, J.; Jung, K.; Klosterhalfen, B.; Sprenger, T.; Conradi, L.-C. & Langer, C. et al. (2012)
BMC Surgery, 12 art. 3. DOI: https://doi.org/10.1186/1471-2482-12-3
Details DOI PMID PMC WoS
-
2012 | Journal Article
Optimal Lymph Node Harvest in Rectal Cancer (UICC Stages II and III) after Preoperative 5-FU-based Radiochemotherapy. Acetone Compression is a New and Highly Efficient Method
Gehoff, A.; Basten, O.; Sprenger, T.; Conradi, L.-C.; Bismarck, C.; Bandorski, D. & Merkelbach-Bruse, S. et al. (2012)
American Journal of Surgical Pathology, 36(2) pp. 202-213. DOI: https://doi.org/10.1097/PAS.0b013e31823fa35b
Details DOI PMID PMC WoS
-
2012 | Journal Article
Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: A planning study with clinical implications
Wolff, H. A.; Wagner, D. M. ; Conradi, L.-C.; Hennies, S.; Ghadimi, M. B.; Hess, C. F. & Christiansen, H. (2012)
Radiotherapy and Oncology, 102(1) pp. 30-37. DOI: https://doi.org/10.1016/j.radonc.2011.10.018
Details DOI PMID PMC WoS
-
2013 | Journal Article
Association of CD133 expression levels with the k-ras mutation status in rectal cancers before and after preoperative radiochemotherapy.
Sprenger, T.; Gaedcke, J.; Conradi, L.-C.; Jo, P.; Jung, K.; Beissbarth, T. & Homayounfar, K. et al. (2013)
Journal of Clinical Oncology, 31(4_suppl) pp. 400-400. DOI: https://doi.org/10.1200/jco.2013.31.4_suppl.400
Details DOI
-
2013 | Conference Abstract
Dual blockade of IGF-IR and EGFR sensitizes colorectal cancer cells to 5-FU-based radiochemotherapy in vitro and in vivo
Kaulfuss, S.; Oberthuer, R.; Meyer, J.; Seemann, H. ; Conradi, L.-C.; Rave-Fraenk, M. & Scharf, J.-G. et al. (2013)
European Journal of Cancer, 49 European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, NETHERLANDS.
Oxford: Elsevier Sci Ltd.
Details WoS
-
2013 | Journal Article |
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.
Quack, H.; Erpenbeck, L.; Wolff, H. A.; Sprenger, T.; Seitz, C. S.; Schön, M. P. & Neumann, S. et al. (2013)
Case reports in oncology, 6(3) pp. 609-615. DOI: https://doi.org/10.1159/000357166
Details DOI PMID PMC
-
2014 | Journal Article
HER2 and HER3 expression in hepatic metastases of colorectal cancer: New targets for specific treatment approaches?
Conradi, L.-C.; Styczen, H.; Sprenger, T.; Wolff, H. A.; Middel, P.; Nagelmeier, I. & Rüschoff, J. et al. (2014)
Journal of Clinical Oncology, 32(3_suppl) pp. 567-567.
Details WoS
-
2014 | Journal Article
Residual rectal cancer after preoperative radiochemotherapy (ypT1-2): An indication for local excision instead of radical surgery?
Sprenger, T.; Rothe, H.; Conradi, L.-C.; Homayounfar, K.; Beissbarth, T. ; Ghadimi, B. M. & Liersch, T. (2014)
Journal of Clinical Oncology, 32(3_suppl) pp. 546-546. DOI: https://doi.org/10.1200/jco.2014.32.3_suppl.546
Details DOI
-
2014 | Journal Article
Surgical Study Culture in european Countries Results of CHIR-Net International Visiting Programs
Mihaljevic, A. L.; Egert, S.; Tenckhoff, S.; Schirren, R.; Conradi, L.-C.; Schumacher, C. & Neugebauer, E. et al. (2014)
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie, 139(5) pp. 469-473.
Details WoS
-
2015 | Journal Article
HER-2 as a potential target for rectal cancer treatment: Positivity rate in patients of the CAO/ARO/AIO-94 and -04 trial
Conradi, L.-C.; Storch, M.; Nagelmeier, I.; Styczen, H.; Wolff, H. A.; Gaedcke, J. & Sprenger, T. et al. (2015)
Journal of Clinical Oncology, 33(3, Suppl.) pp. 585-585. DOI: https://doi.org/10.1200/jco.2015.33.3_suppl.585
Details DOI
-
2015 | Journal Article |
Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
Droege, L. H.; Weber, H. E.; Guhlich, M.; Leu, M.; Conradi, L.-C.; Gaedcke, J. & Hennies, S. et al. (2015)
BMC Cancer, 15 art. 750. DOI: https://doi.org/10.1186/s12885-015-1812-x
Details DOI PMID PMC WoS
-
2016 | Journal Article | Letter Note
Results of the REGATTA trial on surgical therapy of limited metastatic gastric cancer: open issues and future perspectives
Conradi, L.-C.; Lordick, F. & Pircher, A. (2016)
Translational Cancer Research, 5 pp. S178-S181. DOI: https://doi.org/10.21037/tcr.2016.07.25
Details DOI WoS
-
2016 | Conference Abstract
Heterogeneity of KRAS Mutation Status in Rectal Cancer
Jo, P.; Kitz, J.; Conradi, L.-C.; Azizian, A.; Bernhardt, M.; Wolff, H. A. & Schirmer, M. A. et al. (2016)
Oncology Research and Treatment, 39
Basel: Karger.
Details WoS
-
2016 | Journal Article |
Heterogeneity of KRAS Mutation Status in Rectal Cancer
Jo, P.; Koenig, A. O.; Schirmer, M.; Kitz, J.; Conradi, L.-C.; Azizian, A. & Bernhardt, M. et al. (2016)
PLoS ONE, 11(4) art. e0153278. DOI: https://doi.org/10.1371/journal.pone.0153278
Details DOI PMID PMC WoS
-
2017 | Journal Article | Research Paper
The utilization of multidiciplinary tumor boards (MDT) in clinical routine: Results of a health care research study focusing on patients with metastatic colorectal cancer
Homayounfar, K.; Lowes, M.; Kleiss, M.; Lueck, R.; Detken, S.; Nietert, M. & Beißbarth, T. et al. (2017)
Journal of Clinical Oncology, 35(4, Suppl.) pp. 805-805. DOI: https://doi.org/10.1200/JCO.2017.35.4_suppl.805
Details DOI
-
2018 | Journal Article
FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
Fromme, J. E.; Schmitz, K.; Wachter, A.; Grzelinski, M.; Zielinski, D.; Koppel, C. & Conradi, L.-C. et al. (2018)
Oncotarget, 9(63) pp. 32204-32218. DOI: https://doi.org/10.18632/oncotarget.25941
Details DOI PMID PMC